Currently, the share price for Chandra Bhagat Pharma Ltd. is delayed. Login to view live prices.
Chandra Bhagat Pharma Ltd.
₹62.60
BSE
-- ( -- %) 1D
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Operating Revenue | 221.37 | +84.98% |
| Other Income | 11.33 | +3806.90% |
| Total Income | 232.70 | +93.97% |
| Total Expenditure | 230.44 | +93.97% |
| EBIDT | 4.29 | +18.84% |
| Depreciation | 0.64 | +137.04% |
| Interest | 1.39 | -36.53% |
| Tax | 0.73 | +180.77% |
| Net Profit | 1.53 | +68.13% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Total Current Assets | 97.92 | +66.25% |
| Total Non-Current Assets | 3.89 | +130.18% |
| Fixed assets | 2.52 | +245.21% |
| Total assets | 101.80 | +68.04% |
| Total Current Liabilities | 71.06 | +163.67% |
| Total Non-Current Liabilities | 1.74 | -71.75% |
| Total Capital Plus Liabilities | 101.80 | +68.04% |
| Total Shareholder Funds | 29.01 | +5.57% |
| Total Debt to Equity | 0.57 | -17.39% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Cash from Operating Activity | 6.18 | +17.49% |
| Cash from Financing Activities | -5.80 | +30.34% |
| Cash from Investing Activities | -1.85 | +2983.33% |
| Net Cash Flow | -1.48 | -294.74% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer